These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. The IAEA technical cooperation programme and nuclear medicine in the developing world: objectives, trends, and contributions. Casas-Zamora JA; Kashyap R Semin Nucl Med; 2013 May; 43(3):172-80. PubMed ID: 23561454 [TBL] [Abstract][Full Text] [Related]
25. Ensuring the future of nuclear medicine and molecular imaging. Atcher RW J Nucl Med; 2008 Oct; 49(10):27N, 32N. PubMed ID: 18832119 [No Abstract] [Full Text] [Related]
26. New isotope production company gearing up for nuclear medicine industry. Kotz D J Nucl Med; 1998 Apr; 39(4):17N-18N, 27N. PubMed ID: 9544653 [No Abstract] [Full Text] [Related]
27. [Nuclear medicine 2001 and "Guidelines for use of radioactivity in medicine": consequences for nuclear medicine]. Reiners C; Schicha H Nuklearmedizin; 2002; 41(4):168-70. PubMed ID: 12224399 [No Abstract] [Full Text] [Related]
28. The Department of Energy's role in isotope availability for nuclear medicine research. Lash TR J Nucl Med; 1998 May; 39(5):22N, 25N. PubMed ID: 9591567 [No Abstract] [Full Text] [Related]
29. Radioimmunotherapy with alpha-particle emitting radionuclides. Zalutsky MR; Pozzi OR Q J Nucl Med Mol Imaging; 2004 Dec; 48(4):289-96. PubMed ID: 15640792 [TBL] [Abstract][Full Text] [Related]
30. Physics experiment may cloud future of Los Alamos nuclear medicine program. Ketchum LE J Nucl Med; 1987 Sep; 28(9):1371-8. PubMed ID: 3625291 [No Abstract] [Full Text] [Related]
31. Where have all the neutrons gone? Lewis DM Eur J Nucl Med; 1995 Apr; 22(4):297-8. PubMed ID: 7607258 [No Abstract] [Full Text] [Related]
33. [Nuclear cardiology. I. Basic concepts]. Thom AF; Martins LR Arq Bras Cardiol; 1982 Jul; 39(1):53-8. PubMed ID: 7168688 [No Abstract] [Full Text] [Related]
34. [Medium half-life radionuclides for medical use]. Guillaume M Rev Med Liege; 1980 Sep; 35(17):587-97. PubMed ID: 7455438 [No Abstract] [Full Text] [Related]
35. [Nuclear medicine: current aspects and future]. Fridrich R; Müller-Brand J Schweiz Med Wochenschr Suppl; 1988; 25():17-29. PubMed ID: 3041577 [TBL] [Abstract][Full Text] [Related]
36. Thematic planning: the role of the International Atomic Energy Agency in promoting education, medical research, and technology transfer among nuclear medicine communities of developing countries. Padhy AK; Dondi M Semin Nucl Med; 2008 Mar; 38(2):S2-4. PubMed ID: 18243840 [TBL] [Abstract][Full Text] [Related]
37. Veterinary nuclear medicine. Krzemiński M; Lass P; Teodorczyk J; Krajka J Nucl Med Rev Cent East Eur; 2004; 7(2):177-82. PubMed ID: 15968607 [No Abstract] [Full Text] [Related]
38. The promise of targeted {alpha}-particle therapy. Mulford DA; Scheinberg DA; Jurcic JG J Nucl Med; 2005 Jan; 46 Suppl 1():199S-204S. PubMed ID: 15653670 [TBL] [Abstract][Full Text] [Related]
39. Symposium on therapeutic intervention in nuclear medicine--an introduction. Al-Nahhas A; Padhy A Nucl Med Commun; 2002 Sep; 23(9):827-8. PubMed ID: 12195083 [No Abstract] [Full Text] [Related]
40. Cyclotron production of Ac-225 for targeted alpha therapy. Apostolidis C; Molinet R; McGinley J; Abbas K; Möllenbeck J; Morgenstern A Appl Radiat Isot; 2005 Mar; 62(3):383-7. PubMed ID: 15607913 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]